Topical Antibiotics and Intravitreous Injections
NCT00410891
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
129
Enrollment
OTHER
Sponsor class
Conditions
Intravitreous
Injections
Interventions
DRUG:
gatifloxacin
Sponsor
Stanford University